Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Trial participants needed to have a BMI of 30 kg/m 2 or a BMI of 27 kg/m 2 plus a previous diagnosis of 1 or more weight-related comorbidities defined as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
Croatian Institute of Public Health (CIPH)
The generic debut comes after Novo Nordisk, in 2019, failed to pay a $250 CAD maintenance fee on Canadian patent CA 2601784
A study in the Journal of Neurology, Neurosurgery, and Psychiatry found it helped patients with diabetic neuropathy
US$ 29.46
US$ 24.10
US$ 21.00
US$ 20.40
US$ 29.17
US$ 29.16
US$ 21.86
US$ 23.96
US$ 28.91
